Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 8
1980 3
1981 3
1982 2
1983 2
1984 5
1985 8
1986 8
1987 5
1988 15
1989 12
1990 13
1991 16
1992 16
1993 29
1994 22
1995 32
1996 33
1997 63
1998 56
1999 43
2000 64
2001 59
2002 76
2003 83
2004 113
2005 140
2006 163
2007 199
2008 240
2009 248
2010 332
2011 383
2012 449
2013 562
2014 632
2015 675
2016 771
2017 881
2018 1051
2019 1200
2020 1423
2021 1664
2022 1905
2023 1335
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

13,562 results

Results by year

Filters applied: . Clear all
Page 1
Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance.
Chu Y, Dai E, Li Y, Han G, Pei G, Ingram DR, Thakkar K, Qin JJ, Dang M, Le X, Hu C, Deng Q, Sinjab A, Gupta P, Wang R, Hao D, Peng F, Yan X, Liu Y, Song S, Zhang S, Heymach JV, Reuben A, Elamin YY, Pizzi MP, Lu Y, Lazcano R, Hu J, Li M, Curran M, Futreal A, Maitra A, Jazaeri AA, Ajani JA, Swanton C, Cheng XD, Abbas HA, Gillison M, Bhat K, Lazar AJ, Green M, Litchfield K, Kadara H, Yee C, Wang L. Chu Y, et al. Among authors: cheng xd. Nat Med. 2023 Jun;29(6):1550-1562. doi: 10.1038/s41591-023-02371-y. Epub 2023 May 29. Nat Med. 2023. PMID: 37248301
Multi-omics blood atlas reveals unique features of immune and platelet responses to SARS-CoV-2 Omicron breakthrough infection.
Wang H, Liu C, Xie X, Niu M, Wang Y, Cheng X, Zhang B, Zhang D, Liu M, Sun R, Ma Y, Ma S, Wang H, Zhu G, Lu Y, Huang B, Su P, Chen X, Zhao J, Wang H, Shen L, Fu L, Huang Q, Yang Y, Wang H, Wu C, Ge W, Chen C, Huo Q, Wang Q, Wang Y, Geng L, Xie Y, Xie Y, Liu L, Qi J, Chen H, Wu J, Jiang E, Jiang W, Wang X, Shen Z, Guo T, Zhou J, Zhu P, Cheng T. Wang H, et al. Among authors: cheng x. Immunity. 2023 Jun 13;56(6):1410-1428.e8. doi: 10.1016/j.immuni.2023.05.007. Epub 2023 May 16. Immunity. 2023. PMID: 37257450 Free PMC article.
Sparcl1 and Atherosclerosis.
Cheng X, Chen X, Zhang M, Wan Y, Ge S, Cheng X. Cheng X, et al. J Inflamm Res. 2023 May 17;16:2121-2127. doi: 10.2147/JIR.S406907. eCollection 2023. J Inflamm Res. 2023. PMID: 37220502 Free PMC article. Review.
KPNB1-mediated nuclear import in cancer.
Shi Q, Lin M, Cheng X, Zhang Z, Deng S, Lang K, Yang Z, Sun X. Shi Q, et al. Among authors: cheng x. Eur J Pharmacol. 2023 Sep 15;955:175925. doi: 10.1016/j.ejphar.2023.175925. Epub 2023 Jul 18. Eur J Pharmacol. 2023. PMID: 37473981 Review.
Tumor-associated myeloid cells in cancer immunotherapy.
Cheng X, Wang H, Wang Z, Zhu B, Long H. Cheng X, et al. J Hematol Oncol. 2023 Jul 6;16(1):71. doi: 10.1186/s13045-023-01473-x. J Hematol Oncol. 2023. PMID: 37415162 Free PMC article. Review.
Recent Advances in Covalent Drug Discovery.
Schaefer D, Cheng X. Schaefer D, et al. Among authors: cheng x. Pharmaceuticals (Basel). 2023 Apr 28;16(5):663. doi: 10.3390/ph16050663. Pharmaceuticals (Basel). 2023. PMID: 37242447 Free PMC article. Review.
13,562 results
You have reached the last available page of results. Please see the User Guide for more information.